Autoimmune disease preceding amyotrophic lateral sclerosis: An epidemiologic study
Open accessAbstract
OBJECTIVE: To study whether the risk of amyotrophic lateral sclerosis (ALS) is increased in people with prior autoimmune disease. METHODS: An all-England hospital record-linkage dataset spanning 1999-2011 was used. Cohorts were constructed of people with each of a range of autoimmune diseases; the incidence of ALS in each disease cohort was compared with the incidence of ALS in a cohort of individuals without prior admission for the autoimmune disease. RESULTS: There were significantly more cases than expected of ALS associated with a prior diagnosis of asthma, celiac disease, younger-onset diabetes (younger than 30 years), multiple sclerosis, myasthenia gravis, myxedema, polymyositis, Sjögren syndrome, systemic lupus erythematosus, and ulcerative colitis. CONCLUSIONS: Autoimmune disease associations with ALS raise the possibility of shared genetic or environmental risk factors.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Misclassification of some type 1 diabetes cases as type 2 would most likely have underestimated the real inverse association between type 2 diabetes and ALS risk.
“Considering that diabetes mellitus type 1 has been shown to have a positive association with the risk of ALS, we expect that the misclassification of some cases of diabetes mellitus type 1 as type 2 would most likely have underestimated the real inverse association between diabetes type 2 and risk of ALS [38, 41].”
From Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study (2024) · cites this paper as [41]
The Results passage (page unavailable) reports an increased ALS rate ratio for people whose first recorded diagnosis of insulin-dependent diabetes was before age 30, but not for those with that diagnosis across all ages. The paper does not assess whether misclassifying type 1 diabetes as type 2 would underestimate an inverse association; that is the citing authors’ inference, not a finding of this source. (LLM, conf=0.85)
Experimental — accuracy not yet measuredDiabetes mellitus type 1 has been shown to have a positive association with the risk of ALS.
“Considering that diabetes mellitus type 1 has been shown to have a positive association with the risk of ALS, we expect that the misclassification of some cases of diabetes mellitus type 1 as type 2 would most likely have underestimated the real inverse association between diabetes type 2 and risk of ALS [38, 41].”
From Lifestyle and medical conditions in relation to ALS risk and progression—an introduction to the Swedish ALSrisc Study (2024) · cites this paper as [41]
The Results and table (page not available in our copy) report an increased ALS rate ratio for people whose first recorded diagnosis of insulin-dependent diabetes was before age 30. They report no increase for people with a coded diagnosis of insulin-dependent diabetes across all ages, so the unqualified claim about type 1 diabetes is broader than the finding. (LLM, conf=0.90)
Experimental — accuracy not yet measuredPatients with autoimmune diseases showed a slightly increased frequency of developing ALS.
“Moreover, patients with autoimmune diseases showed a slightly increased frequency of developing ALS.86”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [86]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Kiernan, M. C., Vucic, S., Cheah, B. C., Turner, M. R., Eisen, A., Hardiman, O., Burrell, J. R., & Zoing, M. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61156-7 · Cited by 2,603 · see citing works
Self-citationHaverkamp, L. J., Appel, V., & Appel, S. H. (1995) · Brain · doi:10.1093/brain/118.3.707 · Cited by 697 · see citing works
Energy metabolism in amyotrophic lateral sclerosis
Dupuis, L., Pradat, P., Ludolph, A. C., & Loeffler, J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70224-6 · Cited by 537 · see citing works
Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players
Chio, A. (2005) · Brain · doi:10.1093/brain/awh373 · Cited by 484 · see citing works
Oligodendrocyte dysfunction in the pathogenesis of amyotrophic lateral sclerosis
Philips, T., Bento‐Abreu, A., Nonneman, A., Haeck, W., Staats, K. A., Geelen, V., Hersmus, N., Küsters, B., Bosch, L. V. D., Damme, P. V., et al. (2013) · Brain · doi:10.1093/brain/aws339 · Cited by 261 · see citing works
Premorbid weight, body mass, and varsity athletics in ALS
Scarmeas, N., Shih, T., Stern, Y., Ottman, R., & Rowland, L. P. (2002) · Neurology · doi:10.1212/wnl.59.5.773 · Cited by 235 · see citing works
Seminog, O. O., & Goldacre, M. J. (2012) · Thorax · doi:10.1136/thoraxjnl-2012-202480 · Cited by 182 · see citing works
Self-citationTDP-43 frontotemporal lobar degeneration and autoimmune disease
Miller, Z. A., Rankin, K. P., Graff-Radford, N. R., Takada, L. T., Sturm, V. E., Cleveland, C. M., Criswell, L. A., Jaeger, P. A., Stan, T., Heggeli, K. A., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304644 · Cited by 170 · see citing works
Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis
Gallo, V., Wark, P. A., Jenab, M., Pearce, N. E., Brayne, C., Vermeulen, R. C. H., Andersen, P. M., Hallmans, G., Kyrozis, A., Vanacore, N., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182840689 · Cited by 156 · see citing works
Lifetime physical activity and the risk of amyotrophic lateral sclerosis
Huisman, M. H. B., Seelen, M., de Jong, S. W., Dorresteijn, K. R. I. S., van Doormaal, P. T. C., van der Kooi, A. J., de Visser, M., Schelhaas, H. J., van den Berg, L. H., & Veldink, J. H. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304724 · Cited by 156 · see citing works
Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis
Sutedja, N. A., van der Schouw, Y. T., Fischer, K., Sizoo, E. M., Huisman, M. H. B., Veldink, J. H., & van den Berg, L. H. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.236752 · Cited by 144 · see citing works
Fois, A. F., Wotton, C. J., Yeates, D., Turner, M. R., & Goldacre, M. J. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.175463 · Cited by 143 · see citing works
Self-citationHematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis
Appel, S. H., Engelhardt, J. I., Henkel-Tigges, J., Siklós, L., Beers, D. R., Yen, A. A., Simpson, E. P., Luo, Y., Carrum, G., Heslop, H., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000327668.43541.22 · Cited by 140 · see citing works
Epidemiology of amyotrophic lateral sclerosis
Kurtzke, J. F., & Beebe, G. W. (1980) · Neurology · doi:10.1212/wnl.30.5.453 · Cited by 136 · see citing works
Gunnarsson, L., Bodin, L., Söderfeldt, B. A., & Axelson, O. (1992) · Occupational and Environmental Medicine · doi:10.1136/oem.49.11.791 · Cited by 126 · see citing works
Evidence for autoimmunity in amyotrophic lateral sclerosis
Appel, S. H., Smith, R. G., Engelhardt, J. I., & Stefani, E. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90106-9 · Cited by 121 · see citing works
Appel, S. H. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520030026007 · Cited by 105 · see citing works
Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis
Körner, S., Kollewe, K., Ilsemann, J., Müller-Heine, A., Dengler, R., Krampfl, K., & Petri, S. (2012) · European Journal of Neurology · doi:10.1111/ene.12015 · Cited by 101 · see citing works
Turner, M. R., Wotton, C. J., Talbot, K., & Goldacre, M. J. (2011) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301161 · Cited by 71 · see citing works
Self-citationIsmail, A., Cooper-Knock, J., Highley, J. R., Milano, A., Kirby, J., Goodall, E., Lowe, J., Scott, I., Constantinescu, C. S., Walters, S. J., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303326 · Cited by 65 · see citing works
Familial risks for amyotrophic lateral sclerosis and autoimmune diseases
Hemminki, K., Li, X., Sundquist, J., & Sundquist, K. (2008) · Neurogenetics · doi:10.1007/s10048-008-0164-y · Cited by 33 · see citing works
Antecedent Medical Diseases in Patients With Amyotrophic Lateral Sclerosis
Armon, C. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530150051017 · Cited by 32 · see citing works
A case of celiac disease mimicking amyotrophic lateral sclerosis
Turner, M. R., Chohan, G., Quaghebeur, G., Greenhall, R., Hadjivassiliou, M., & Talbot, K. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0631 · Cited by 32 · see citing works
Self-citationTurner, M. R. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-304935 · Cited by 30 · see citing works
Self-citationMultiple sclerosis and amyotrophic lateral sclerosis: is there a link?
Etemadifar, M., Abtahi, S.-H., Akbari, M., & Maghzi, A. (2011) · Multiple Sclerosis Journal · doi:10.1177/1352458511427719 · Cited by 30 · see citing works
Associated autoimmune diseases in patients with multifocal motor neuropathy and their family members
Cats, E. A., Bertens, A. S., Veldink, J. H., van den Berg, L. H., & van der Pol, W. L. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6315-3 · Cited by 27 · see citing works
HLA Frequencies in Amyotrophic Lateral Sclerosis
Bartfeld, H., Pollack, M. S., Cunningham-Rundles, S., & Donnenfeld, H. (1982) · Archives of Neurology · doi:10.1001/archneur.1982.00510170012003 · Cited by 15 · see citing works
Amyotrophic lateral sclerosis is not linked to multiple sclerosis in a population based study
van Doormaal, P. T. C., Gallo, A., van Rheenen, W., Veldink, J. H., van Es, M. A., & van den Berg, L. H. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304864 · Cited by 11 · see citing works
Flagged first, then by citations
Research works printed but not linked: 1
- Turner MR, Wotton C, Talbot K, Goldacre MJ. Cardio- vascular fitness as a risk factor for amyotrophic lateral scle- rosis: indirect evidence from record linkage study. J Neurol Neurosurg Psychiatry 2012;83:395-398.
Cited by
Sorted by citations
Role of neuroinflammation in neurodegeneration development
Zhang, W., Xiao, D., Mao, Q., & Xia, H. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01486-5 · Cited by 1,668 · see citing works
Risk factors for amyotrophic lateral sclerosis
Fang, F., Ingre, C., Roos, P. M., Kamel, F., & Piehl, F. (2015) · Clinical Epidemiology · doi:10.2147/clep.s37505 · Cited by 470 · see citing works
ALS Genetics: Gains, Losses, and Implications for Future Therapies
Kim, G., Gautier, O., Tassoni-Tsuchida, E., Ma, X. R., & Gitler, A. D. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.022 · Cited by 370 · see citing works
Role of the cGAS–STING pathway in systemic and organ-specific diseases
Skopelja‐Gardner, S., An, J., & Elkon, K. B. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00589-6 · Cited by 315 · see citing works
C9orf72 in myeloid cells suppresses STING-induced inflammation
McCauley, M. E., O’Rourke, J. G., Yáñez, A., Markman, J. L., Ho, R., Wang, X., Chen, S., Lall, D., Jin, M., Muhammad, A. K. M. G., et al. (2020) · Nature · doi:10.1038/s41586-020-2625-x · Cited by 298 · see citing works
Loss-of-function mutations in the <i>C9ORF72</i> mouse ortholog cause fatal autoimmune disease
Burberry, A., Suzuki, N., Wang, J.-Y., Moccia, R., Mordes, D. A., Stewart, M. H., Suzuki-Uematsu, S., Ghosh, S., Singh, A., Merkle, F. T., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf6038 · Cited by 269 · see citing works
Energy metabolism in ALS: an underappreciated opportunity?
Vandoorne, T., Bock, K. D., & Bosch, L. V. D. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1835-x · Cited by 260 · see citing works
Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging
Santulli, G., & Marks, A. R. (2015) · Current Molecular Pharmacology · doi:10.2174/1874467208666150507105105 · Cited by 212 · see citing works
Bonafede, R., & Mariotti, R. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00080 · Cited by 205 · see citing works
Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia
Lall, D., & Baloh, R. H. (2017) · Journal of Clinical Investigation · doi:10.1172/jci90607 · Cited by 175 · see citing works
Systemic inflammatory response and neuromuscular involvement in amyotrophic lateral sclerosis
Lu, C., Allen, K., Oei, F., Leoni, E., Kühle, J., Tree, T. I. M., Fratta, P., Sharma, N., Sidle, K. C. L., Howard, R., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000244 · Cited by 172 · see citing works
C9ORF72: What It Is, What It Does, and Why It Matters
Smeyers, J., Banchi, E.-G., & Latouche, M. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.661447 · Cited by 175 · see citing works
Myasthenia gravis and risks for comorbidity
Gilhus, N. E., Nacu, A., Andersen, J. B., & Owe, J. F. (2014) · European Journal of Neurology · doi:10.1111/ene.12599 · Cited by 160 · see citing works
Mariosa, D., Hammar, N., Malmström, H., Ingre, C., Jungner, I., Ye, W., Fang, F., & Walldius, G. (2017) · Annals of Neurology · doi:10.1002/ana.24936 · Cited by 151 · see citing works
Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study
Kioumourtzoglou, M.-A., Rotem, R. S., Seals, R. M., Gredal, O., Hansen, J., & Weisskopf, M. G. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.0910 · Cited by 145 · see citing works
Advances in motor neurone disease
Bäumer, D., Talbot, K., & Turner, M. R. (2014) · Journal of the Royal Society of Medicine · doi:10.1177/0141076813511451 · Cited by 134 · see citing works
Self-citationAhmed, R. M., Irish, M., Piguet, O., Halliday, G. M., Ittner, L. M., Farooqi, I. S., Hodges, J. R., & Kiernan, M. C. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00380-4 · Cited by 130 · see citing works
Béland, L.-C., Markovinovic, A., Jakovac, H., De Marchi, F., Bilic, E., Mazzini, L., Kriz, J., & Munitic, I. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa124 · Cited by 125 · see citing works
Association between diabetes and amyotrophic lateral sclerosis in <scp>S</scp>weden
Mariosa, D., Kamel, F., Bellocco, R., Ye, W., & Fang, F. (2015) · European Journal of Neurology · doi:10.1111/ene.12632 · Cited by 120 · see citing works
Increased prevalence of autoimmune disease within C9 and FTD/MND cohorts: Completing the picture
Miller, Z. A., Sturm, V. E., Camsari, G. B., Karydas, A., Yokoyama, J. S., Grinberg, L. T., Boxer, A. L., Rosen, H. J., Rankin, K. P., Gorno-Tempini, M. L., et al. (2016) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000301 · Cited by 100 · see citing works
Prior medical conditions and the risk of amyotrophic lateral sclerosis
Seelen, M., van Doormaal, P. T. C., Visser, A. E., Huisman, M. H. B., Roozekrans, M., de Jong, S. W., van der Kooi, A. J., de Visser, M., Voermans, N. C., Veldink, J. H., et al. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7445-1 · Cited by 100 · see citing works
Zeng, P., Wang, T., Zheng, J., & Zhou, X. (2019) · BMC Medicine · doi:10.1186/s12916-019-1448-9 · Cited by 96 · see citing works
Recent advances in amyotrophic lateral sclerosis
Riva, N., Agosta, F., Lunetta, C., Filippi, M., & Quattrini, A. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8091-6 · Cited by 88 · see citing works
Plasma Inflammatory Cytokines Are Elevated in ALS
Tortelli, R., Zecca, C., Piccininni, M., Benmahamed, S., Dell’Abate, M. T., Barulli, M. R., Capozzo, R., Battista, P., & Logroscino, G. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.552295 · Cited by 84 · see citing works
C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies
Vatsavayai, S. C., Nana, A. L., Yokoyama, J. S., & Seeley, W. W. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1921-0 · Cited by 78 · see citing works
Zamudio, F., Loon, A. R., Smeltzer, S., Benyamine, K., Shanmugam, N. K. N., Stewart, N. J., Lee, D. C., Nash, K. R., & Selenica, M. B. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01952-9 · Cited by 76 · see citing works
The dual roles of immunity in ALS: Injury overrides protection
Murdock, B. J., Bender, D. E., Segal, B. M., & Feldman, E. L. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.017 · Cited by 73 · see citing works
The effects of diet and sex in amyotrophic lateral sclerosis
Pape, J. A., & Grose, J. H. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2019.09.008 · Cited by 70 · see citing works
Zhang, Y., Burberry, A., Wang, J., Sandoe, J., Ghosh, S. D., Udeshi, N. D., Svinkina, T., Mordes, D. A., Mok, J., Charlton, M. E., et al. (2018) · Genes & Development · doi:10.1101/gad.313932.118 · Cited by 69 · see citing works
Neurophysiology of the “Celiac Brain”: Disentangling Gut-Brain Connections
Pennisi, M., Bramanti, A., Cantone, M., Pennisi, G., Bella, R., & Lanza, G. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00498 · Cited by 71 · see citing works
Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis
Zhang, Y., Ogbu, D., Garrett, S., Xia, Y., & Sun, J. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1996848 · Cited by 61 · see citing works
Epidemiology of Amyotrophic Lateral Sclerosis and Effect of Riluzole on Disease Course
Çetin, H., Rath, J., Füzi, J., Reichardt, B., Fülöp, G., Koppi, S., Erdler, M., Ransmayr, G. N., Weber, J., Neumann, K., et al. (2015) · Neuroepidemiology · doi:10.1159/000369813 · Cited by 59 · see citing works
Antecedent Disease Is Less Prevalent in Amyotrophic Lateral Sclerosis
Mitchell, C. S., Hollinger, S. K., Goswami, S. D., Polak, M. A., Lee, R. H., & Glass, J. D. (2015) · Neurodegenerative Diseases · doi:10.1159/000369812 · Cited by 52 · see citing works
McAlpine, W., Sun, L., Wang, K.-W., Liu, A., Jain, R., Miguel, M. S., Wang, J., Zhang, Z., Hayse, B., McAlpine, S. G., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814753115 · Cited by 51 · see citing works
MicroRNAs as Potential Circulating Biomarkers for Amyotrophic Lateral Sclerosis
Cloutier, F., Marrero, A., O’Connell, C. M., & Morin, P. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0471-8 · Cited by 51 · see citing works
Liquid–liquid phase separation in innate immunity
Liu, D., Yang, J., & Cristea, I. M. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.04.009 · Cited by 49 · see citing works
Pennisi, M., Lanza, G., Cantone, M., Ricceri, R., Ferri, R., D’Agate, C. C., Pennisi, G., Lazzaro, V. D., & Bella, R. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177560 · Cited by 49 · see citing works
Genome-wide genetic links between amyotrophic lateral sclerosis and autoimmune diseases
Li, C. Y., Yang, T. M., Ou, R. W., Wei, Q. Q., & Shang, H. F. (2021) · BMC Medicine · doi:10.1186/s12916-021-01903-y · Cited by 48 · see citing works
Lam, L., Chin, L., Halder, R. C., Sagong, B., Famenini, S., Sayre, J. W., Montoya, D. J., Rubbi, L., Pellegrini, M. A., & Fiala, M. (2016) · The FASEB Journal · doi:10.1096/fj.201600259rr · Cited by 47 · see citing works
The increasing importance of environmental conditions in amyotrophic lateral sclerosis
Riancho, J., Bosque‐Varela, P., Pérez‐Pereda, S., Povedano, M., de Munaín, A. L., & Santurtún, A. (2018) · International Journal of Biometeorology · doi:10.1007/s00484-018-1550-2 · Cited by 47 · see citing works
Transglutaminase 6 Antibodies in the Serum of Patients With Amyotrophic Lateral Sclerosis
Gadoth, A., Nefussy, B., Bleiberg, M., Klein, T., Artman, I., & Drory, V. E. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.48 · Cited by 44 · see citing works
Serious Neurologic Adverse Events in Tofersen Clinical Trials for Amyotrophic Lateral Sclerosis
Lovett, A., Chary, S., Babu, S., Bruneteau, G., Glass, J. D., Karlsborg, M., Ladha, S. S., Mayl, K., McDermott, C. J., Bucelli, R. C., et al. (2025) · Muscle & Nerve · doi:10.1002/mus.28372 · Cited by 39 · see citing works
Autoimmune Disease Classification Based on PubMed Text Mining
Samuels, H., Malov, M., Saha, T., Zaken, K. B., Bloch, N., Gal-Tanamy, M., Avni, O., Polis, B., & Samson, A. O. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11154345 · Cited by 38 · see citing works
Disease-modifying effects of metabolic perturbations in ALS/FTLD
Jawaid, A., Khan, R., Polymenidou, M., & Schulz, P. E. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0294-0 · Cited by 37 · see citing works
Blood hemoglobin A1c levels and amyotrophic lateral sclerosis survival
Wei, Q.-Q., Chen, Y., Cao, B., Ou, R., Zhang, L., Hou, Y., Gao, X., & Shang, H. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0211-y · Cited by 37 · see citing works
The links between diabetes mellitus and amyotrophic lateral sclerosis
Vasta, R., D’Ovidio, F., Logroscino, G., & Chiò, A. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05099-0 · Cited by 38 · see citing works
Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging
Coder, B., Wang, W., Wang, L., Wu, Z., Zhuge, Q., & Su, D. (2016) · Oncotarget · doi:10.18632/oncotarget.12572 · Cited by 35 · see citing works
Fernández-Beltrán, L. C., Godoy-Corchuelo, J. M., Losa-Fontangordo, M., Williams, D. J., Matías‐Guiu, J., & Corrochano, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179553 · Cited by 32 · see citing works
Quessada, C., Bouscary, A., René, F., Valle, C., Ferri, A., Ngo, S. T., & Loeffler, J. (2021) · Cells · doi:10.3390/cells10061449 · Cited by 32 · see citing works
Molecular Pathology of ALS: What We Currently Know and What Important Information Is Still Missing
Jankovská, N., & Matěj, R. (2021) · Diagnostics · doi:10.3390/diagnostics11081365 · Cited by 32 · see citing works
Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis
Nelson, A. T., & Trotti, D. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01262-3 · Cited by 31 · see citing works
Goris, A., van Setten, J., Diekstra, F. P., Ripke, S., Patsopoulos, N. A., Sawcer, S. J., van Es, M. A., Andersen, P. M., Melki, J., Meininger, V., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt574 · Cited by 31 · see citing works
Associations between autoimmune diseases and amyotrophic lateral sclerosis: a register-based study
Cui, C., Longinetti, E., Larsson, H., Andersson, J., Yudi Pawitan, Y., Piehl, F., & Fang, F. (2020) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2020.1861022 · Cited by 30 · see citing works
Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder
Marchi, F. D., Franjkic, T., Schito, P., Russo, T., Nimac, J., Chami, A. A., Mele, A., Vidatic, L., Križ, J., Julien, J., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11061599 · Cited by 28 · see citing works
The role of magnetic fields in neurodegenerative diseases
Riancho, J., de la Torre, J. R. S., Paz‐Fajardo, L., Limia, C., Santurtún, A., Cifra, M., Kourtidis, K., & Fdez-Arróyabe, P. (2020) · International Journal of Biometeorology · doi:10.1007/s00484-020-01896-y · Cited by 29 · see citing works
Type II diabetes mellitus and the incidence of amyotrophic lateral sclerosis
Tsai, C., Lee, J. K.-W., & Lee, C. T. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09405-x · Cited by 28 · see citing works
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants
Marchi, F. D., Tondo, G., Corrado, L., Menegon, F., Aprile, D., Anselmi, M., D’Alfonso, S., Comi, C., & Mazzini, L. (2023) · Genes · doi:10.3390/genes14081658 · Cited by 28 · see citing works
Viuff, M. H., Stochholm, K., Juul, S., & Gravholt, C. H. (2022) · European Journal of Human Genetics · doi:10.1038/s41431-021-00989-5 · Cited by 27 · see citing works
Myasthenia gravis and amyotrophic lateral sclerosis: A pathogenic overlap
Gotaas, H. T., SKEIE, G. O., & Gilhus, N. E. (2016) · Neuromuscular Disorders · doi:10.1016/j.nmd.2016.03.003 · Cited by 26 · see citing works
Amyotrophic lateral sclerosis: a complex syndrome that needs an integrated research approach
Riancho, J., Gil-Bea, F. J., Santurtún, A., & de Munaín, A. L. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.244783 · Cited by 26 · see citing works
Amador, M. D. M., Vandenberghe, N., Berhoune, N., Camdessanché, J., Gronier, S., Delmont, É., Desnuelle, C., Cintas, P., Pittion, S., Léonard-Louis, S., et al. (2016) · Neuromuscular Disorders · doi:10.1016/j.nmd.2016.03.004 · Cited by 25 · see citing works
Tai, H., Cui, L., Guan, Y., Liu, M., Li, X., Huang, Y., Yuan, J., Shen, D., Li, D., & Zhai, F. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00218 · Cited by 26 · see citing works
Alipour, P., Senkevich, K. A., Ross, J. P., Spiegelman, D., Manousaki, D., Dion, P. A., & Rouleau, G. A. (2022) · BMC Medicine · doi:10.1186/s12916-022-02578-9 · Cited by 25 · see citing works
Tsai, C., Hu, C., & Lee, C. T. (2018) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2018.1522354 · Cited by 24 · see citing works
Ponomarenko, M. P., Arkova, O. V., Рассказов, Д. А., Ponomarenko, P. M., Savinkova, L. K., & Kolchanov, N. A. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00130 · Cited by 23 · see citing works
Are diabetes and amyotrophic lateral sclerosis related?
Logroscino, G. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.145 · Cited by 23 · see citing works
Amyotrophic lateral sclerosis and myasthenia gravis: association or chance occurrence?
Pasqua, S. D., Cavallieri, F., D’Angelo, R., Salvi, F., Fini, N., D’Alessandro, R., Rinaldi, R., Fasano, A., & Mandrioli, J. (2016) · Neurological Sciences · doi:10.1007/s10072-016-2787-3 · Cited by 22 · see citing works
C9ORF72 protein function and immune dysregulation in amyotrophic lateral sclerosis
Lai, J. D., & Ichida, J. K. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134523 · Cited by 23 · see citing works
Rodríguez, M. J., & Mahy, N. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867324666161123091314 · Cited by 21 · see citing works
Zanini, G., Selleri, V., Nasi, M., Gaetano, A. D., Martinelli, I., Gianferrari, G., Lofaro, F. D., Boraldi, F., Mandrioli, J., & Pinti, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911881 · Cited by 21 · see citing works
Hypothalamus and weight loss in amyotrophic lateral sclerosis
Ahmed, R. M., Steyn, F. J., & Dupuis, L. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-820107-7.00020-3 · Cited by 20 · see citing works
Factors predicting disease progression in C9ORF72 ALS patients
Mandrioli, J., Zucchi, E., Martinelli, I., der Most, L. V., Gianferrari, G., Moglia, C., Manera, U., Solero, L., Vasta, R., Canosa, A., et al. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11426-y · Cited by 20 · see citing works
Target Metabolites to Slow Down Progression of Amyotrophic Lateral Sclerosis in Mice
Ogbu, D., Zhang, Y., Claud, K., Xia, Y., & Sun, J. (2022) · Metabolites · doi:10.3390/metabo12121253 · Cited by 20 · see citing works
Chen, L., Wang, N., Zhang, Y. N., Li, D., He, C., Li, Z., Zhang, J., & Guo, Y. (2022) · Journal of Proteomics · doi:10.1016/j.jprot.2022.104776 · Cited by 19 · see citing works
Ludvigsson, J. F., Mariosa, D., Lebwohl, B., & Fang, F. (2014) · European Journal of Neurology · doi:10.1111/ene.12419 · Cited by 19 · see citing works
Zheng, W., Wang, K., Wu, Y., Ge, Y., Zhang, C., Li, Z., Wang, L., & Chen, S. (2022) · Theranostics · doi:10.7150/thno.76138 · Cited by 17 · see citing works
Trageser, K. J., Yang, E., Smith, C., Iban‐Arias, R., Oguchi, T., Sebastian-Valverde, M., Iqbal, U. H., Wu, H. D., Estill, M. S., Rahim, M. A., et al. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03315-w · Cited by 18 · see citing works
Riancho, J., Delgado‐Alvarado, M., Andreu, M. D., Paz‐Fajardo, L., Arozamena, S., Gil-Bea, F. J., & de Munaín, A. L. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15151 · Cited by 17 · see citing works
Wannarong, T., & Ungprasert, P. (2020) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2020.106248 · Cited by 18 · see citing works
Effects of exercise on neuroinflammation in age-related neurodegenerative disorders
Su, Y., & Su, Z. (2025) · European journal of medical research · doi:10.1186/s40001-025-03165-3 · Cited by 18 · see citing works
Analysis of the US Safety Data for Edaravone (Radicava®) From the Third Year After Launch
Genge, A. L., Brooks, B. R., Oskarsson, B., Kalin, A., Ji, M. H., Apple, S., & Bower, L. (2022) · Drugs in R&D · doi:10.1007/s40268-022-00391-6 · Cited by 17 · see citing works
Myeloid and lymphoid expression of C9orf72 regulates IL-17A signaling in mice
Limone, F., Couto, A., Wang, J.-Y., Zhang, Y., McCourt, B. T., Huang, C., Minkin, A., Jani, M., McNeer, S. K., Keaney, J., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg7895 · Cited by 16 · see citing works
Diabetes Mellitus and Amyotrophic Lateral Sclerosis: A Systematic Review
Ferri, L., Ajdinaj, P., Rispoli, M. G., Carrarini, C., Barbone, F., D’Ardes, D., Capasso, M., Muzio, A. D., Cipollone, F., ONOFRJ, M. C., et al. (2021) · Biomolecules · doi:10.3390/biom11060867 · Cited by 16 · see citing works
Takahashi, H., Noto, Y., Makita, N., Kushimura-Okada, Y., Ishii, R., Tanaka, A., Ohara, T., Nakane, S., Higuchi, O., Nakagawa, M., et al. (2016) · BMC Neurology · doi:10.1186/s12883-016-0758-1 · Cited by 15 · see citing works
Zong, J., Yang, Y. X., Wang, H., Zhang, H., Yang, X., & Yang, X. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1325908 · Cited by 14 · see citing works
Cooccurrences of Putative Endogenous Retrovirus-Associated Diseases
Brütting, C., Emmer, A., Kornhuber, M. E., & Staege, M. S. (2017) · BioMed Research International · doi:10.1155/2017/7973165 · Cited by 14 · see citing works
Very Early Involvement of Innate Immunity in Peripheral Nerve Degeneration in SOD1-G93A Mice
Angelini, D. F., Angelis, F. D., Vacca, V., Piras, E., Parisi, C., Nutini, M., Spalloni, A., Pagano, F., Longone, P., Battistini, L., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.575792 · Cited by 14 · see citing works
Diabetes mellitus in amyotrophic lateral sclerosis: Dr Jekyll or Mr Hyde?
Jawaid, A., Brown, J. A., & Schulz, P. E. (2015) · European Journal of Neurology · doi:10.1111/ene.12660 · Cited by 14 · see citing works
No association between gluten sensitivity and amyotrophic lateral sclerosis
Visser, A. E., Pazoki, R., Pulit, S. L., van Rheenen, W., Raaphorst, J., van der Kooi, A. J., Ricaño-Ponce, I., Wijmenga, C., Otten, H. G., Veldink, J. H., et al. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8400-8 · Cited by 12 · see citing works
Prevalence of motor neuron diseases in gout patients: a nationwide population-based cohort study
Kwon, H. S., Park, Y., Kim, J. H., Kim, S. H., Jun, J., Park, S., Kang, D. R., & Choi, H. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06451-8 · Cited by 12 · see citing works
Aberrant protein aggregation in amyotrophic lateral sclerosis
Wang, H., & Zeng, R. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12485-z · Cited by 11 · see citing works
Aluminum?s Role in CNS-immune System Interactions leading to Neurological Disorders
Shaw, C. A. (2013) · Immunome Research · doi:10.4172/1745-7580.1000069 · Cited by 11 · see citing works
Phase separation in immune regulation and immune-related diseases
Huang, N., Dong, H., & Shao, B. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02253-9 · Cited by 11 · see citing works
Anti-inflammatory therapies of amyotrophic lateral sclerosis guided by immune pathways.
Lam, L., Halder, R. C., Montoya, D. J., Rubbi, L., Rinaldi, A. O., Sagong, B., Weitzman, S. A., Rubattino, R., Singh, R. R., Pellegrini, M. A., et al. (2015) · PubMed Central · Cited by 11 · see citing works
Chourpiliadis, C., Seitz, C., Lovik, A., Joyce, E. E., Pan, L., Hu, Y., Kläppe, U., Samuelsson, K., Press, R., Ingre, C., et al. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12496-w · Cited by 10 · see citing works
Does Glyphosate Acting as a Glycine Analogue Contribute To ALS?
Seneff, S. (2016) · JOURNAL OF BIOINFORMATICS AND PROTEOMICS REVIEW · doi:10.15436/2381-0793.16.1173 · Cited by 10 · see citing works
Ohnari, K., Okada, K., Higuchi, O., Matsuo, H., & Adachi, H. (2018) · Internal Medicine · doi:10.2169/internalmedicine.0966-18 · Cited by 10 · see citing works
Geevasinga, N., Burrell, J. R., Hibbert, M., Vucic, S., & Ng, K. (2014) · European Journal of Neurology · doi:10.1111/ene.12347 · Cited by 9 · see citing works
Naum, R., & Gwathmey, K. G. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98818-6.00004-2 · Cited by 9 · see citing works
- Authors
- Turner, M. R., Goldacre, R., Ramagopalan, S., Talbot, K., & Goldacre, M. J.
- Affiliations
- John Radcliffe Hospital (GB)
- Venue
- Neurology
- Published
- 2013-10
- Volume
- 81
- Issue
- 14
- Pages
- 1222-1225
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC3795611
- OpenAlex
- W2167295920
- Cited by
- 185
- References
- 28
- Citations by year
- 2026: 2 · 2025: 13 · 2024: 12 · 2023: 13 · 2022: 22 · 2021: 19 · 2020: 19 · 2019: 8 · 2018: 12 · 2017: 13 · 2016: 18 · 2015: 20 · 2014: 11 · 2013: 2
- FWCI
- 10.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neurology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Motor Neurone Disease Association (TURNER/JAN13/944-795)
- Medical Research Council (MR/K01014X/1)
- Topics
- Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Neurology › Peripheral Neuropathies and Disorders
- Keywords
- amyotrophic lateral sclerosis, autoimmune disease, asthma, celiac disease, multiple sclerosis, myasthenia gravis, myxedema, polymyositis, Sjögren's syndrome, systemic lupus erythematosus, ulcerative colitis, type 1 diabetes, ALS incidence, genetic risk factors, environmental risk factors
- MeSH terms
- Amyotrophic Lateral Sclerosis, Autoimmune Diseases, England, Female, Hospital Records, Humans, Male, Risk, Cohort Studies, Comorbidity, Incidence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review